CONSENT AND THIRD LOAN MODIFICATION AGREEMENTConsent and Third Loan Modification Agreement • November 14th, 2017 • Western Capital Resources, Inc. • Personal credit institutions • North Carolina
THIS CONSENT AND THIRD LOAN MODIFICATION AGREEMENT (this “Agreement”), is made and entered into as of October 3, 2017, by and among WESTERN CAPITAL RESOURCES, INC., a Delaware corporation (the “Borrower”), EACH OF THE UNDERSIGNED SUBSIDIARIES OF THE BORROWER (together with the Borrower, collectively, the “Loan Parties”, and each, individually, a “Loan Party”), and FIFTH THIRD BANK, an Ohio corporation (together with its successors and assigns, the “Lender”).
CONSENT AND THIRD LOAN MODIFICATION AGREEMENTConsent and Third Loan Modification Agreement • April 21st, 2011 • Trustwave Holdings, Inc.
This Consent and Third Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of March 1, 2010, by and among SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 380 Interlocken Crescent, Suite 600, Broomfield, Colorado 80021 (“Bank”), TRUSTWAVE HOLDINGS, INC., a Delaware corporation (“Holdings”), TRUSTWAVE INTERMEDIATE, INC., a Delaware corporation (“Intermediate”), and TW VERICEPT CORPORATION, a Delaware corporation (formerly known as “TrustWave Acquisition, Inc.,” “Vericept” and individually and collectively, jointly and severally, with Holdings, and Intermediate, “Borrower”).
CONSENT AND THIRD LOAN MODIFICATION AGREEMENTConsent and Third Loan Modification Agreement • March 3rd, 2015 • Mavenir Systems Inc • Computer communications equipment
This Consent and Third Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of January 16, 2015 (the “Third Loan Modification Effective Date”), by and among (i) SILICON VALLEY BANK, a California corporation with a loan production office located at 14185 Dallas Parkway, Suite 760, Dallas TX 75254 (“Bank”), (ii) MAVENIR SYSTEMS, INC., a Delaware corporation (“Mavenir”), (iii) MAVENIR HOLDINGS, INC., a Delaware corporation (“Holdings”), (iv) MAVENIR SYSTEMS IP HOLDINGS, LLC, a Delaware limited liability company (“Mavenir IP”) each with offices located at 1700 International Parkway, Suite 200, Richardson, TX 75081, (v) MAVENIR SYSTEMS HOLDINGS LIMITED, a company registered under the laws of England and Wales under company number 05181808 whose registered office is at 76 Wallingford Road, Shillingford, Oxfordshire OX10 7EU, United Kingdom (“U.K. Holdings”), (vi) MAVENIR SYSTEMS UK LIMITED, a company registered under the laws of England and Wales under company
CONSENT AND THIRD LOAN MODIFICATION AGREEMENTConsent and Third Loan Modification Agreement • March 3rd, 2014 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
This Consent and Third Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of December 12, 2013, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and AEGERION PHARMACEUTICALS, INC., a Delaware corporation with its chief executive office located at 101 Main Street, Suite 1850, Cambridge, Massachusetts 02142 (“Borrower”).
